Follow us on Twitter
twitter icon@FreshPatents


Factor patents

      

This page is updated frequently with new Factor-related patent applications.




 Tool-less storage device adaptor tray with spring mechanism patent thumbnailnew patent Tool-less storage device adaptor tray with spring mechanism
A storage device tray has a form factor designed to support a larger storage device, and is configured to secure a small storage device, thereby acting as an adapter between storage device sizes. The storage device tray includes a clip configured with pegs that may couple to screw hole sin the storage device.
Super Micro Computer, Inc.


 Wiring board and memory system including the same patent thumbnailnew patent Wiring board and memory system including the same
A memory system includes a package having a memory device, and a wiring board to which the package is attached. The wiring board includes a first region and a second region separable from the first region.
Samsung Electronics Co., Ltd.


 Tool-less storage device adaptor tray with slider mechanism patent thumbnailnew patent Tool-less storage device adaptor tray with slider mechanism
A storage device tray has a form factor designed to support a larger storage device, and is configured to secure a small storage device, thereby acting as an adapter between storage device sizes. The storage device tray includes a sliding mechanism configured with pegs that may couple to screw holes in the storage device.
Super Micro Computer, Inc.


 Churn risk scoring using call network analysis patent thumbnailnew patent Churn risk scoring using call network analysis
Customer churn risk scores are based on a multi-variable churn risk model relating customer and customer account characteristics to a risk of customer churn. A computer-implemented method of generating and presenting churn risk scores of customers of a telecommunication provider involves analyzing, on an in-memory database platform, customer call data records and customer records to calculate a churn likelihood value, an influence factor value, and an average spend value for each customer.
Sap Se


 Active optical cable module for cable system patent thumbnailnew patent Active optical cable module for cable system
A module having first and second ends, and comprising at least one circuit board extending from the first end to the second end; at least one electrical connector at the first end, the at least one electrical connector being electrically connected to the circuit board, the electrical connector having a form factor of a standard electrical connector; at least one optical connector at the second end; a plurality of optical electrical devices (oeds) disposed on the circuit board, wherein the oeds are connected electrically to the at least one electrical connector through the circuit board, and wherein the oeds are connected optically to at least one optical connector.. .
Tyco Electronics Corporation


 Methods and compositions for diagnosis and prognosis of renal injury and renal failure patent thumbnailnew patent Methods and compositions for diagnosis and prognosis of renal injury and renal failure
The present invention relates to methods and compositions for monitoring, diagnosis, prognosis, and determination of treatment regimens in subjects suffering from or suspected of having a renal injury. In particular, the invention relates to using a one or more assays configured to detect a kidney injury marker selected from the group consisting of heat shock 70 kda protein 1, alpha-1-antitrypsin neutrophil elastase complex, stromelysin-1:metalloproteinase inhibitor 2 complex, 72 kda type iv collagenase:metalloproteinase inhibitor 2 complex, insulin-like growth factor 1 receptor, myeloid differentiation primary response protein myd88, neuronal cell adhesion molecule, and tumor necrosis factor ligand superfamily member 10 as diagnostic and prognostic biomarkers in renal injuries..
Astute Medical, Inc.


 Multifactorial process optimisation method and system patent thumbnailnew patent Multifactorial process optimisation method and system
A method and system for increasing process performance in a biological process comprising at least one process step, the method comprising: (a) an identification phase, in which at least seven factors are identified, wherein a factor is defined as a feature of or within a process that when modified will affect the performance of the process, and wherein the factors are selected from at least one process factor and at least one genetic factor; (b) a factor screening phase, in which individual and combined contributions to process performance of each of the at least seven factors are determined, such that at least one multi-factorial interaction is identified; and (c) a refinement phase, in which higher order interactions that result in an increase in process performance between the at least seven factors are identified and tested. The method may be incorporated within automated laboratory and design of experiment systems..
Synthace Limited


 Modified gene conferring virus resistance patent thumbnailnew patent Modified gene conferring virus resistance
The present invention relates to modified rdr1 gene capable of conferring virus resistance to a plant and/or increasing virus resistance in a plant, which modification results in enhanced expression of the rdr1 gene, and wherein the modification is selected from a modification that increases the mrna level of the rdr1 gene; a modification that increases the level of the rdr1 protein; and/or a modification that increases the activity of the rdr1 protein, as compared to a non-modified wild-type rdr1 gene. The modification may comprise a modification upstream of the coding sequence of the rdr1 gene, such as a modification of a regulatory element, preferably of a cis-acting regulatory element.
Rijk Zwaan Zaadteelt En Zaadhandel B.v.


 Agents for enhancement of production of biofuel precursors in microalgae patent thumbnailnew patent Agents for enhancement of production of biofuel precursors in microalgae
We identified 17 transcription factor genes that regulate lipid production and activity in an organism. We subsequently detailed characterization of one of them (psr1).
The Regents Of The University Of California


 Biomatrix scaffolds patent thumbnailnew patent Biomatrix scaffolds
The present invention provides biomatrix scaffolds, a tissue extract enriched for extracellular matrix components and bound growth factors, cytokines and hormones, and methods of making and using same.. .
The University Of North Carolina At Chapel Hill


new patent

Insulin-like growth factor 1 receptor -specific antibodies and uses thereof

The blood-brain barrier (bbb) prevents transport of molecules larger than 500 daltons from blood to brain. Receptor-mediated transcytosis (rmt) facilitates transport across the bbb of specific molecules that bind receptors on brain endothelial cells that form the bbb.
National Research Council Of Canada

new patent

Insulin-like growth factor 1 receptor -specific antibodies and uses thereof

The blood-brain barrier (bbb) prevents transport of molecules larger than 500 dal tons from blood to brain. Receptor-mediated transcytosis (rmt) facilitates transport across the bbb of specific molecules that bind receptors on brain endothelial cells that form the bbb.
National Research Council Of Canada

new patent

Anticoagulant

The present invention provides an anti-blood coagulant capable of selectively suppressing a pathological blood coagulation reaction without increasing the risk of major bleeding. The anti-blood coagulant in accordance with the present invention includes a binding inhibiting component that inhibits the binding of lox-1 to at least one of factor v and factor va..
Shinshu University

new patent

Factor viii fusion protein

The present invention relates to modified coagulation factors. In particular, the present invention relates to conjugated factor viii molecules fused to a polypeptide such as e.g.
Novo Nordisk A/s

new patent

Sulfonamides derived from tricyclyl-2-aminocycloalkanols as anticancer agents

The compounds induce foxo1 transcription factor translocation to the nucleus by modulating pp2a and, as a consequence, exhibit anti-proliferative effects. They are useful in the treatment of a variety of disorders, including as a monotherapy in cancer treatment, or used in combination with other drugs to restore sensitivity to chemotherapy where resistance has developed..

new patent

Platelet-derived growth factor compositions and methods of use thereof

A method for promoting growth of bone, periodontium, ligament, or cartilage in a mammal by applying to the bone, periodontium, ligament, or cartilage a composition comprising platelet-derived growth factor at a concentration in the range of about 0.1 mg/ml to about 1.0 mg/ml in a pharmaceutically acceptable liquid carrier and a pharmaceutically-acceptable solid carrier.. .
Biomimetic Therapeutics, Llc

new patent

Unit dose formulation of antidotes for factor xa inhibitors and methods of using the same

The present invention relates unit dose formulations of antidotes to anticoagulants targeting factor xa. Disclosed herein are methods of stopping or preventing bleeding in a patient that is currently undergoing anticoagulant therapy with a factor xa inhibitor..
Portola Pharmaceuticals, Inc.

new patent

Methods for treating wounds

Novel compositions for treating wounds and promoting the healing thereof are described, including composition containing novel combinations of a carrier and recombinant platelet derived growth factor having fewer isoforms and enhanced biostability. Methods of treating wounds with novel therapeutic composition using dosing procedures leading to effective results with a minimal number of treatment applications are also described..

new patent

Platelet-derived growth factor compositions and methods of use thereof

A method for promoting growth of bone, periodontium, ligament, or cartilage in a mammal by applying to the bone, periodontium, ligament, or cartilage a composition comprising platelet-derived growth factor at a concentration in the range of about 0.1 mg/ml to about 1.0 mg/ml in a pharmaceutically acceptable liquid carrier and a pharmaceutically-acceptable solid carrier.. .
Biomimetic Therapeutics, Llc

new patent

Platelet-derived growth factor compositions and methods of use thereof

A method for promoting growth of bone, periodontium, ligament, or cartilage in a mammal by applying to the bone, periodontium, ligament, or cartilage a composition comprising platelet-derived growth factor at a concentration in the range of about 0.1 mg/ml to about 1.0 mg/ml in a pharmaceutically acceptable liquid carrier and a pharmaceutically-acceptable solid carrier.. .
Biomimetic Therapeutics, Llc

new patent

Induction of thyroid iodide-handling gene expression in human cancers

Dual suppression of the map kinase and pi3k/akt pathways showed synergistic or greatly enhanced anti-melanoma cell effects, compared to suppression of a single pathway, including the inhibition of cell proliferation, transformation and invasion, induction of g0/g1 cell cycle arrest and, importantly, cell apoptosis. Remarkably, suppression of either pathway induces the expression of thyroid iodide-handling genes and dual suppression of the two pathways synergistically and robustly induces expression of these genes, accompanied by uptake of radioiodine in the cells.
The Johns Hopkins University

new patent

Proactive repellent and camp perimeter defense against apex predators

A proactive repellent and camp perimeter defense against apex predators is provided. In an implementation, the proactive repellent is a liquid agent or aerosol tuned to the sensitive olfactory senses of apex predators.
Camp Gard Llc

Multifactorial scoring method and system

Method, systems and apparatus to determine the suitability of parts or protocols to perform unit operations in the context of a biological process, comprising recording of a user score associated with an instance of use of a protocol or part, wherein the context of the use is recorded along with the rating, and wherein the context is defined as the value of factors that may affect the performance of the unit operation in which the part or protocol was used. The method may be implemented as a web service..
Synthace Limited

Diagnosis of cancer by detecting auto-antibodies against epidermal growth factor (egf)

The present invention relates to a method for diagnosis of a cancer, comprising the steps of (i) determining the level of antibodies against epidermal growth factor (egf) in a sample from a subject to be diagnosed, (ii) comparing the determined level in the sample to a control level derived from subjects without cancer; wherein a decreased level in the sample from the subject to be diagnosed as compared to the control level is indicative for cancer in the subject. Furthermore, the invention relates to method of predicting response and outcome of a treatment of a cancer with an epidermal growth factor receptor inhibitor..
Celltrend Gmbh

Igfbp7 for diagnosing diastolic dysfunction

The present invention relates to a method for diagnosing and/or grading diastolic dysfunction or at least one structural or functional abnormality associated with diastolic dysfunction. The method comprises measuring the level of igfbp7 (insulin like growth factor binding protein 7) and, optionally, the level of at least one further marker in a patient suffering from heart failure, and comparing the level to a reference level.
Roche Diagnostics Operations, Inc.

Gdf15 as biomarker for diagnosing mitochondrial diseases

To obtain data associated with a mitochondrial disease, a method includes measuring the level of at least one protein selected from the group consisting of gdf15 (growth differentiation factor 15), hgf (hepatocyte growth factor), mig (gamma interferon induction monokine), scf (stem cell factor) and scgf-β (stem cell growth factor beta) in a biological sample collected from a subject. The measured protein level is compared to that of control subjects and then it is checked whether or not there is difference between the protein level of the subject and that of control subjects..
Kurume University

Diagnosis of cancer by detecting auto-antibodies against egf-receptor

The present invention relates to a method for diagnosis of a cancer, comprising the steps of (i) determining the level of antibodies against epidermal growth factor receptor (egfr) in a sample from a subject to be diagnosed, (ii) comparing the determined level in the sample to a control level derived from subjects without cancer; wherein a decreased level in the sample from the subject to be diagnosed as compared to the control level is indicative for cancer in the subject. Furthermore, the invention relates to method of predicting response and outcome of a treatment of a cancer with an inhibitor of egfr activity..
Celltrend Gmbh

Led light fixture and assembly method therefor

An led panel light fixture and method for assembling the same includes (a) selecting a set of specifications of the led panel light fixture, the set of specifications comprising a fixture/base specification comprising a form factor of the led panel light fixture; and a top specification comprising a visual feature of a top in accordance with the top specification; (b) providing a knock-down kit having parts including the top in accordance with the top specification, a frame in accordance with the fixture/base specification, an optically transmissive panel assembly, a set of light emitting diodes (leds), and driving circuitry; and (c) assembling the led panel light fixture using parts of the knock-down kit. An led panel lighting fixture kit includes a top and a base.
Pixi Lighting, Inc.

Biocontrol

Provided is an arthropod male germline gene expression system suitable for conditional expression of an effector gene in an arthropod male germline. The system comprises a first expression unit comprising an effector gene and a promoter therefor operably linked thereto; and a second expression unit.
Oxitec Limited

Production of therapeutic proteins in photosynthetic organisms

The present disclosure relates to methods of expressing therapeutic proteins in photosynthetic organisms and the therapeutic proteins produced by the methods. The therapeutic proteins include high-mobility group box 1 (hmgb1) protein, fibronectin domain (10) (10fn3), fibronectin domain (14) (14fn3), interferon beta (ifnβ), proinsulin and vascular endothelial growth factor (vegf).
The Scripps Research Institute

Autopilot system for an aircraft and related process

An autopilot system for an aircraft and related process are provided. The system includes a first load factor command definition and application module; a second roll command definition and application module; a control module of the first definition and application module and the second definition and application module, able to define parameters of a recovery maneuver seeking to return the aircraft to setpoint attitudes at the end of a maneuver from initial attitudes.
Dassault Aviation

Image recording device having a compact form factor

An image recording device is provided, having a recording unit configured to record an image on a sheet, and a tray disposed below the recording unit. The tray includes a sheet holding surface configured to hold the sheet.
Brother Kogyo Kabushiki Kaisha

Patient programmer having a key-fob-sized form factor

A patient programmer has a housing having a key-fob-sized form factor. The patient programmer has electrical circuitry implemented inside the housing.
Nuvectra Corporation

Pharmaceutical composition for cancer treatment and pharmaceutical preparation for cancer treatment containing same composition as active ingredient

The invention provides a novel anticancer therapeutic having a high effect against solid cancers, lacking the side effects of chemotherapeutics, and being unlikely to cause resistance. Provided is a pharmaceutical composition for cancer treatment prepared by a method having: a stem cell production step for making immortalized stem cells by introducing four types of genes into deciduous tooth dental pulp stem cells obtained from the dental pulp of mammals; and a condition medium preparation step for culturing the immortalized stem cells for a predetermined length of time in serum-free medium at 23-27° c.
Quarrymen Corporation

Method of treating intraocular tissue pathologies

Nerve growth factor (ngf), in the form of a preparation to be administered over ocular surface, is suggested as being suitable for therapy and/or prophylaxis of intraocular tissue pathologies, with particular reference to sclera, ciliary body, crystalline lens, retina, optic nerve, vitreous body and choroidea affections. When administered in the form of external ophthlamic preparation, for example as collyrium or ointment, ngf is capable to go through ocular tissues and it has been found out that it shows a therapeutic activity not only against retina and optic nerve pathologies but also against affections involving the above reported internal structures of the eye..
Dompé Farmaceutici S.p.a.

Contemporaneous, heterogeneously-oriented, multi-targeted therapeutic modification and/or modulation of disease by administration of sulfur-containing, amino acid-specific small molecules

The present invention discloses and claims novel pharmaceutical compositions, methods, and kits used for the contemporaneous, heterogeneously-oriented, multi-targeted therapeutic modification and/or modulation of cellular metabolic anomalies or other undesirable physiological conditions, including cancer, where the normal cellular biochemical function and/or the expression levels of various proteins/enzymes (i.e., the target molecules) are abnormal and must be modified and/or modulated in order to treat these metabolic anomalies or other undesirable physiological conditions, including cancer. The aforementioned target molecules, by way of non-limiting example, include: anaplastic lymphoma kinase (alk), mesenchymal epithelial transition (met) kinase, the receptor tyrosine kinase (ros1), epidermal growth factor receptor (egfr), peroxiredoxin (prx), excision repair cross-complementing protein 1 (ercc1), insulin growth factor 1 receptor (igf1r), ribonucleotide reductase (rnr), tubulin, farnesyltransferase, and various other classes of proteins/enzymes.
Bionumerik Pharmaceuticals, Inc.





Follow us on Twitter
twitter icon@FreshPatents

###

This listing is a sample listing of patent applications related to Factor for is only meant as a recent sample of applications filed, not a comprehensive history. There may be associated servicemarks and trademarks related to these patents. Please check with patent attorney if you need further assistance or plan to use for business purposes. This patent data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Factor with additional patents listed. Browse our RSS directory or Search for other possible listings.


0.9853

file did exist - 2662

1 - 1 - 52